REG - GlaxoSmithKline PLC - Director/PDMR Shareholding

GSKAnnouncement

16/04/2019 17:25

RNS Number : 4052W
GlaxoSmithKline PLC
16 April 2019
 


GlaxoSmithKline plc (the 'Company')
Transaction notification
 




1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Mr S P Dingemans




b)


Position/status


Executive Director




c)


Initial notification/
amendment


Initial notification




2.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


GlaxoSmithKline plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
 




a)


Description of the financial instrument


Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
 
 




b)


Nature of the transaction


Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 11 April 2019 on Ordinary Shares held in the Company's Performance Share Plan, subject to a 2-year holding period.
 




c)


Price(s) and volume(s)






Price(s)


Volume(s)




£15.6560


2220.684




£15.6560


2397.921




 




d)


Aggregated information
 
Aggregated volume Price


 
4618.605
 
 
£15.6560
 




e)


Date of the transaction




2019-04-12




f)


Place of the transaction
 


London Stock Exchange (XLON)




 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQQLFFKZFFBBK